Top Story

New CVD risk score can be adjusted for use in any country

March 27, 2015

A new risk equation can be recalibrated for application in any country with routinely available information, researchers reported in The Lancet Diabetes & Endocrinology.

The risk score, called Globorisk, measures risk for CHD or stroke in adults aged 40 years and older by factoring in smoking status, BP, diabetes status and total cholesterol, while adjusting for the effects of age and sex on CVD in different countries. Adding BMI to the risk factors did not improve risk prediction, the researchers wrote.

Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…
Paul Sorajja, MD Meeting News CoveragePerspective

First report of US commercial data for transcatheter mitral valve repair system shows favorable outcomes

March 27, 2015
SAN DIEGO — In the first report of U.S. commercial experience with transcatheter mitral valve repair presented at American College of Cardiology Scientific…
In the Journals

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health…
Guy Young, MD In the Journals

Investigation programs needed for study of risks in use of pediatric anticoagulant drugs

March 27, 2015
The International Society on Thrombosis and Haemostasis called for the development of pediatric investigative programs to study risks of anticoagulants in children and…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
4132203130001 th

VIDEO: New IMPROVE-IT analyses reinforce benefits of greater cholesterol reduction

March 24, 2015
SAN DIEGO — In this video, Christopher P. Cannon, MD, of Brigham and Women's Hospital in Boston, discusses two…
More »
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
morganatic-roan